Hemp 101

The US Cannabis Market in 2025: Size, Trends, Top States, and What Comes Next

By June 8, 2026June 10th, 2026No Comments
US cannabis market statistics showing dispensary and American flag with market growth chart

The United States is home to the world’s largest legal cannabis market. Despite federal prohibition still being in place as of 2025, the state-by-state patchwork of legal frameworks has produced a market that generates more annual revenue than the US craft beer industry and more than Starbucks’s entire US retail operation.

US Cannabis Market Size: The Key Numbers

The US legal cannabis retail market generated approximately $33.8 billion in sales in 2025, up approximately 5% from $32.1 billion in 2024. The market is projected to reach $76.4 billion by 2030, growing at a compound annual growth rate of 11.51%. To put these figures in context: the US legal cannabis market in 2025 is larger than the US craft beer market ($28 billion) and generates more revenue than Starbucks’s US retail sales.

Growth was uneven across states. Newly launched adult-use markets in New York, Maryland, New Jersey, Ohio, and Minnesota posted strong double-digit gains. Mature West Coast markets including California, Colorado, Washington, and Oregon contracted between 4% and 9% due to wholesale price compression and persistent competition from the illicit market.

Top US State Markets by Revenue (2025)

California remains the largest single state market at approximately $4.06 billion, down from its 2021 peak of $5.2 billion. Michigan is the second-largest market at $3.49 billion, followed by Florida (medical only, $2.25 billion), Illinois ($2.18 billion), Colorado ($1.9 billion), New York ($1.5 billion and scaling rapidly), and New Jersey ($1.2 billion). Ohio recorded significant gains in its first full year of adult-use sales in 2025.

Product Category Breakdown (US, 2025)

Flower accounts for 39.6% of total US cannabis retail sales. Vape cartridges and disposables hold 27%. Edibles including gummies, chocolates, and beverages account for 14.4%. Pre-rolls hold 13.2%. Concentrates and extracts account for 5.1%. Topicals and other formats make up the remaining share.

Notable trends within these categories include the rapid growth of infused pre-rolls pushing 35 to 45% THC and low-dose edibles under 5 mg per serving. These two sub-formats are capturing new consumers at opposite ends of the potency spectrum.

Medical vs Recreational

The US cannabis market is dominated by the recreational segment, which held approximately 87.7% of total revenue in 2024. The medical segment, while smaller in revenue terms, represents high-margin transactions due to specific formulations, dosing requirements, and patient loyalty. Florida remains a particularly notable medical-only market, generating over $2.25 billion purely from state-licensed medical dispensaries.

The Federal Prohibition Problem

The most significant constraint on the US cannabis market continues to be federal prohibition under the Controlled Substances Act. Federal illegality creates banking exclusion from traditional financial services, 280E tax treatment where cannabis businesses cannot deduct normal business expenses creating effective tax rates often exceeding 70% of gross profit, restrictions on interstate commerce preventing economies of scale, and limitations on stock exchange listings.

Federal rescheduling discussions accelerated in 2024 and 2025. The DEA proposed moving cannabis from Schedule I to Schedule III, a change that would address the 280E tax burden without full federal legalisation. As of 2025 this process remained ongoing.

Five-Year Outlook

The projected compound annual growth rate for the US legal cannabis market is 12.2% from 2025 through 2030. Key growth drivers include new state markets still in early ramp phases, the potential of Florida adult-use legalisation adding $4 to $6 billion alone, federal rescheduling improving profitability, product innovation attracting wellness-oriented demographics, and continued price compression shifting consumers from the illicit to the legal market.


Frequently Asked Questions

How big is the US cannabis market in 2025?

The US legal cannabis retail market generated approximately $33.8 billion in sales in 2025, up about 5% from $32.1 billion in 2024. This makes the US by far the largest legal cannabis market in the world, accounting for approximately 54% of global legal cannabis sales.

Which US state has the largest cannabis market?

California remains the largest single US state cannabis market with approximately $4.06 billion in 2025 sales, though this is down from its 2021 peak of $5.2 billion. Michigan is the second-largest market at $3.49 billion, followed by Florida, Illinois, and Colorado.

Is cannabis legal across the whole United States?

No. Cannabis remains federally illegal in the US under the Controlled Substances Act as of 2025. However, 24 states plus Washington DC have legalised adult recreational use, and 38 states allow medical cannabis. This creates a state-by-state patchwork where legality, product availability, and regulations differ significantly by location.

What is the most popular cannabis product in the US?

Dried cannabis flower is the most popular product category in the US, accounting for approximately 39.6% of total retail sales. Vape products are second at 27%, followed by edibles at 14.4% and pre-rolls at 13.2%. Infused pre-rolls and low-dose edibles under 5 mg are among the fastest-growing sub-formats.

What is preventing federal cannabis legalisation in the US?

Federal cannabis legalisation faces obstacles including political disagreement, regulatory complexity, banking and tax code reform implications, and international treaty obligations. The DEA proposed moving cannabis to Schedule III in 2024, which would provide significant relief on the tax issue without full legalisation. Full federal legalisation is generally expected to be a longer-term development.

Leave a Reply